🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/06/2019 26,34 26,87 26,17 26,37 -2,30% 2,66% 1.822.500
11/06/2019 26,71 27,05 26,19 26,99 +1,70% 3,22% 1.098.500
10/06/2019 27,50 27,69 26,36 26,54 -1,89% 4,85% 1.279.000
07/06/2019 26,65 27,10 26,54 27,05 +1,65% 2,10% 1.318.800
06/06/2019 26,37 26,96 25,94 26,61 +0,72% 3,87% 1.403.900
05/06/2019 25,74 26,62 25,40 26,42 +3,41% 4,74% 1.743.800
04/06/2019 24,78 25,58 24,27 25,55 +4,67% 5,30% 2.160.900
03/06/2019 24,15 24,88 23,90 24,41 +2,95% 4,06% 1.990.400
31/05/2019 24,16 24,29 23,49 23,71 -3,62% 3,31% 2.369.300
30/05/2019 25,12 25,23 24,27 24,60 -1,56% 3,83% 2.062.900
29/05/2019 24,69 25,50 24,12 24,99 -0,12% 5,57% 2.029.300
28/05/2019 24,40 25,39 24,08 25,02 +4,12% 5,37% 3.990.000
24/05/2019 21,96 24,30 21,91 24,03 +9,38% 10,88% 5.421.100
23/05/2019 21,47 22,08 20,42 21,97 +0,83% 7,73% 21.001.500
22/05/2019 21,17 22,10 21,17 21,79 +2,06% 4,38% 4.498.100
21/05/2019 20,59 22,74 20,49 21,35 +12,72% 10,93% 11.601.500
20/05/2019 19,15 19,38 18,82 18,94 -2,67% 2,92% 999.500
17/05/2019 19,20 19,95 19,20 19,46 -0,05% 3,91% 1.157.000
16/05/2019 18,96 19,69 18,51 19,47 +1,56% 6,22% 1.276.900
15/05/2019 18,38 19,29 18,23 19,17 +3,06% 5,73% 1.068.800
14/05/2019 18,18 18,98 18,00 18,60 +3,19% 5,39% 1.303.900
13/05/2019 18,98 19,14 17,56 18,03 -7,61% 8,35% 1.721.400
10/05/2019 19,22 19,99 19,05 19,51 +0,31% 4,89% 1.436.500
09/05/2019 18,23 19,57 17,75 19,45 +6,11% 9,96% 1.904.000
08/05/2019 17,99 18,77 17,71 18,33 +1,78% 5,89% 1.337.300
07/05/2019 18,27 18,54 17,68 18,01 -2,91% 4,71% 1.423.300
06/05/2019 17,61 18,76 17,51 18,55 +2,26% 7,10% 1.131.400
03/05/2019 17,90 18,19 17,73 18,14 +1,85% 2,57% 1.042.200
02/05/2019 17,43 17,94 17,30 17,81 +2,18% 3,67% 943.300
01/05/2019 18,00 18,10 17,41 17,43 -3,06% 3,83% 1.221.500